CXCL2 and neoplasm: Tumor-associated fibroblasts can release a variety of chemokines and cytokines, such as IL-6 and CXCL2, to promote the migration and aggregation of Tregs cells into the TME, thereby transforming TME into an immunosuppressor (40).